Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc (GHDX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genomic Health Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1131324.
Total stock buying since 2010: $274,431,226.
Total stock sales since 2010: $560,218,490.
Total stock option exercises since 2010: $58,217,068.
▪ Recent SEC 13D filings for GHDX
▪ Recent SEC 13D filings for all companies
▪ Funds & ETFs holding GHDX
▪ Recent portfolio reports of all companies
A schedule 13D must be filed with the SEC when a person or group of people acquire beneficial ownership of more than 5% of Genomic Health Inc (GHDX). A schedule 13D/A is an amendment that is filed when there are any material changes in beneficial ownership.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 37,643,330 | $0 | 4,255,395 | $302,840,723 | 1,177,273 | $31,943,202 |
| 2018 | 0 | $0 | 2,775,805 | $206,377,815 | 561,292 | $12,545,100 |
| 2017 | 0 | $0 | 218,781 | $6,847,246 | 255,541 | $4,916,282 |
| 2016 | 100,000 | $2,701,600 | 148,242 | $4,293,432 | 181,950 | $3,190,607 |
| 2015 | 0 | $0 | 65,864 | $1,910,548 | 65,864 | $879,494 |
| 2014 | 0 | $0 | 129,133 | $3,710,512 | 127,821 | $901,597 |
| 2013 | 1,291,008 | $44,806,297 | 180,546 | $5,712,858 | 147,830 | $1,549,708 |
| 2012 | 4,285,949 | $123,323,993 | 473,515 | $14,642,933 | 90,100 | $812,659 |
| 2011 | 3,431,794 | $90,242,252 | 411,096 | $10,178,567 | 124,276 | $830,861 |
| 2010 | 916,315 | $13,357,084 | 230,750 | $3,703,856 | 102,234 | $647,558 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-11-14 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 27.24 | 136,215 |
| 2012-11-13 | 667, L.p. (Director) | Buy | 103,839 | 27.99 | 2,906,661 |
| 2012-11-12 | 667, L.p. (Director) | Buy | 200,000 | 27.94 | 5,587,400 |
| 2012-11-12 | Schorno Dean L (CFO) | Sale | 2,800 | 28.00 | 78,400 |
| 2012-11-12 | Schorno Dean L (CFO) | Option Ex | 2,800 | 9.39 | 26,292 |
| 2012-11-09 | 667, L.p. (Director) | Buy | 519,933 | 27.05 | 14,061,587 |
| 2012-11-09 | Schorno Dean L (CFO) | Sale | 200 | 28.00 | 5,600 |
| 2012-11-09 | Schorno Dean L (CFO) | Option Ex | 200 | 9.39 | 1,878 |
| 2012-11-08 | Cole G Bradley (COO) | Sale | 2,500 | 28.62 | 71,542 |
| 2012-11-08 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-10-16 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 35.01 | 175,055 |
| 2012-10-16 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 35.00 | 175,000 |
| 2012-10-16 | Popovits Kimberly J (President and CEO) | Option Ex | 5,000 | 23.31 | 116,550 |
| 2012-10-15 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 31.17 | 155,840 |
| 2012-10-12 | Schorno Dean L (CFO) | Sale | 3,000 | 33.79 | 101,358 |
| 2012-10-12 | Schorno Dean L (CFO) | Option Ex | 3,000 | 9.39 | 28,170 |
| 2012-10-11 | Hibbs Kathy L (SVP & General Counsel) | Sale | 1,250 | 33.78 | 42,223 |
| 2012-10-11 | Hibbs Kathy L (SVP & General Counsel) | Option Ex | 1,250 | 21.07 | 26,337 |
| 2012-10-09 | Cole G Bradley (COO) | Sale | 2,500 | 34.80 | 86,990 |
| 2012-10-09 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-09-18 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 33.76 | 168,800 |
| 2012-09-13 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 31.69 | 158,450 |
| 2012-09-06 | Cole G Bradley (COO) | Sale | 2,500 | 35.01 | 87,515 |
| 2012-09-06 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-08-21 | Myers Woodrow A Jr (Director) | Sale | 10,993 | 35.28 | 387,800 |
| 2012-08-21 | Myers Woodrow A Jr (Director) | Option Ex | 10,993 | 9.95 | 109,380 |
| 2012-08-20 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 34.99 | 174,940 |
| 2012-08-20 | Myers Woodrow A Jr (Director) | Sale | 5,507 | 35.06 | 193,058 |
| 2012-08-20 | Myers Woodrow A Jr (Director) | Option Ex | 5,507 | 9.95 | 54,794 |
| 2012-08-14 | Popovits Kimberly J (President and CEO) | Sale | 3,103 | 35.07 | 108,812 |
| 2012-08-14 | Popovits Kimberly J (President and CEO) | Option Ex | 3,103 | 23.31 | 72,330 |
| 2012-08-13 | Popovits Kimberly J (President and CEO) | Sale | 6,897 | 34.70 | 239,312 |
| 2012-08-13 | Popovits Kimberly J (President and CEO) | Option Ex | 1,897 | 23.31 | 44,219 |
| 2012-08-08 | Cole G Bradley (COO) | Sale | 2,500 | 30.49 | 76,235 |
| 2012-08-08 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-08-01 | Cohen Fred E (Director) | Option Ex | 8,250 | 10.73 | 88,522 |
| 2012-07-26 | Livingston Randall S (Director) | Sale | 2,000 | 35.90 | 71,800 |
| 2012-07-26 | Livingston Randall S (Director) | Option Ex | 2,000 | 1.33 | 2,654 |
| 2012-07-24 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 34.24 | 171,195 |
| 2012-07-13 | Popovits Kimberly J (President and CEO) | Sale | 7,100 | 34.84 | 247,342 |
| 2012-07-13 | Popovits Kimberly J (President and CEO) | Option Ex | 2,100 | 23.31 | 48,951 |
| 2012-07-11 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 35.16 | 527,340 |
| 2012-07-10 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 36.30 | 544,575 |
| 2012-07-05 | Cole G Bradley (COO) | Sale | 2,500 | 35.95 | 89,865 |
| 2012-07-05 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-06-25 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 33.25 | 166,250 |
| 2012-06-13 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 33.36 | 166,805 |
| 2012-06-12 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 33.31 | 499,650 |
| 2012-06-11 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 34.15 | 512,235 |
| 2012-06-06 | Cole G Bradley (COO) | Sale | 2,500 | 33.97 | 84,920 |
| 2012-06-06 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-05-31 | Popovits Kimberly J (President and CEO) | Buy | 919 | 23.11 | 21,239 |
| 2012-05-24 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 33.80 | 168,980 |
| 2012-05-22 | Baker Felix (Director) | Buy | 17,406 | 32.94 | 573,405 |
| 2012-05-21 | Baker Felix (Director) | Buy | 150,000 | 32.12 | 4,818,450 |
| 2012-05-18 | Colella Samuel D (Director) | Sale | 9,300 | 32.13 | 298,790 |
| 2012-05-17 | Colella Samuel D (Director) | Sale | 16,994 | 33.52 | 569,689 |
| 2012-05-16 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 35.00 | 175,000 |
| 2012-05-16 | Popovits Kimberly J (President and CEO) | Option Ex | 5,000 | 23.31 | 116,550 |
| 2012-05-16 | Baker Felix (Director) | Buy | 23,621 | 34.46 | 813,932 |
| 2012-05-15 | Schorno Dean L (CFO) | Sale | 1,000 | 33.69 | 33,686 |
| 2012-05-15 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 33.46 | 167,290 |
| 2012-05-15 | Baker Felix (Director) | Buy | 140,000 | 33.94 | 4,752,160 |
| 2012-05-14 | Baker Felix (Director) | Buy | 212,438 | 32.92 | 6,994,521 |
| 2012-05-11 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 30.74 | 461,145 |
| 2012-05-11 | Baker Felix (Director) | Buy | 26,660 | 30.22 | 805,558 |
| 2012-05-10 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 30.10 | 451,560 |
| 2012-05-10 | Baker Felix (Director) | Buy | 68,681 | 29.92 | 2,054,798 |
| 2012-05-09 | Cole G Bradley (COO) | Sale | 2,500 | 28.87 | 72,172 |
| 2012-05-09 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-05-09 | Baker Felix (Director) | Buy | 19,547 | 29.89 | 584,357 |
| 2012-05-08 | Baker Felix (Director) | Buy | 86,033 | 28.60 | 2,460,543 |
| 2012-05-07 | Baker Felix (Director) | Buy | 56,540 | 28.27 | 1,598,103 |
| 2012-05-04 | Baker Felix (Director) | Buy | 53,128 | 28.01 | 1,488,009 |
| 2012-04-26 | Livingston Randall S (Director) | Sale | 2,000 | 28.21 | 56,428 |
| 2012-04-26 | Livingston Randall S (Director) | Option Ex | 2,000 | 1.33 | 2,654 |
| 2012-04-24 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 27.93 | 139,630 |
| 2012-04-23 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 27.79 | 138,965 |
| 2012-04-16 | Schorno Dean L (CFO) | Sale | 1,000 | 27.98 | 27,980 |
| 2012-04-11 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 10,000 | 28.38 | 283,790 |
| 2012-04-10 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 10,000 | 29.11 | 291,130 |
| 2012-04-04 | Cole G Bradley (COO) | Sale | 2,500 | 30.28 | 75,690 |
| 2012-04-04 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-03-22 | Shak Steven (Chief Medical Officer) | Sale | 10,000 | 30.08 | 300,830 |
| 2012-03-22 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 30.07 | 300,670 |
| 2012-03-15 | Schorno Dean L (CFO) | Sale | 1,000 | 31.08 | 31,080 |
| 2012-03-13 | Scott Randal W (CEO, InVitae Corporation) | Sale | 15,000 | 31.12 | 466,770 |
| 2012-03-12 | Scott Randal W (CEO, InVitae Corporation) | Sale | 15,000 | 30.98 | 464,685 |
| 2012-03-08 | Cole G Bradley (COO) | Sale | 2,500 | 29.94 | 74,850 |
| 2012-03-08 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-03-08 | Baker Felix (Director) | Buy | 22,191 | 30.36 | 673,805 |
| 2012-03-07 | Baker Felix (Director) | Buy | 25,000 | 29.88 | 746,974 |
| 2012-03-05 | Baker Felix (Director) | Buy | 177,710 | 30.01 | 5,333,432 |
| 2012-03-02 | Baker Felix (Director) | Buy | 104,850 | 29.52 | 3,095,170 |
| 2012-03-01 | Baker Felix (Director) | Buy | 17,456 | 29.47 | 514,427 |
| 2012-02-29 | Baker Felix (Director) | Buy | 180,603 | 29.06 | 5,247,961 |
| 2012-02-28 | Baker Felix (Director) | Buy | 58,535 | 29.11 | 1,703,835 |
| 2012-02-27 | Baker Felix (Director) | Buy | 42,125 | 29.03 | 1,222,930 |
| 2012-02-24 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 28.85 | 144,255 |
| 2012-02-23 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 28.14 | 140,725 |
| 2012-02-23 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 28.15 | 140,740 |
| 2012-02-23 | Baker Felix (Director) | Buy | 71,214 | 28.12 | 2,002,822 |
| 2012-02-22 | Baker Felix (Director) | Buy | 6,294 | 27.98 | 176,111 |
| 2012-02-21 | Baker Felix (Director) | Buy | 53,364 | 27.98 | 1,492,964 |
| 2012-02-16 | Baker Felix (Director) | Buy | 211,769 | 29.48 | 6,242,102 |
| 2012-02-15 | Schorno Dean L (CFO) | Sale | 755 | 28.76 | 21,713 |
| 2012-02-15 | Baker Felix (Director) | Buy | 36,918 | 28.88 | 1,066,079 |
| 2012-02-14 | Baker Felix (Director) | Buy | 64,620 | 28.44 | 1,837,598 |
| 2012-02-10 | Scott Randal W (Executive Chairman) | Sale | 10,000 | 26.25 | 262,500 |
| 2012-02-10 | Baker Felix (Director) | Buy | 188,639 | 26.58 | 5,014,212 |
| 2012-02-09 | Scott Randal W (Executive Chairman) | Sale | 10,000 | 26.10 | 261,030 |
| 2012-02-09 | Baker Felix (Director) | Buy | 66,332 | 26.28 | 1,743,005 |
| 2012-02-08 | Cole G Bradley (COO) | Sale | 2,500 | 26.47 | 66,172 |
| 2012-02-08 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-02-08 | Baker Felix (Director) | Buy | 240,570 | 26.20 | 6,302,692 |
| 2012-01-26 | Livingston Randall S (Director) | Sale | 2,000 | 27.51 | 55,020 |
| 2012-01-26 | Livingston Randall S (Director) | Option Ex | 2,000 | 1.33 | 2,654 |
| 2012-01-25 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 26.42 | 132,085 |
| 2012-01-24 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 26.74 | 133,680 |
| 2012-01-24 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 26.62 | 133,080 |
| 2012-01-17 | Schorno Dean L (CFO) | Sale | 1,000 | 28.00 | 27,999 |
| 2012-01-12 | Cole G Bradley (COO) | Sale | 2,500 | 27.54 | 68,845 |
| 2012-01-12 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2012-01-11 | Scott Randal W (Executive Chairman) | Sale | 10,000 | 27.89 | 278,920 |
| 2012-01-10 | Scott Randal W (Executive Chairman) | Sale | 10,000 | 27.35 | 273,530 |
| 2011-12-22 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 26.03 | 130,155 |
| 2011-12-13 | Scott Randal W (Executive Chairman) | Sale | 10,000 | 27.19 | 271,860 |
| 2011-12-12 | Scott Randal W (Executive Chairman) | Sale | 10,000 | 28.01 | 280,080 |
| 2011-12-06 | Cole G Bradley (COO) | Sale | 2,500 | 28.59 | 71,465 |
| 2011-12-06 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2011-12-05 | Baker Felix (Director) | Buy | 24,381 | 28.45 | 693,515 |
| 2011-12-02 | Baker Felix (Director) | Buy | 115,962 | 28.05 | 3,252,268 |
| 2011-12-01 | Baker Felix (Director) | Buy | 26,537 | 27.33 | 725,256 |
| 2011-11-23 | Baker Felix (Director) | Buy | 70,239 | 25.80 | 1,811,814 |
| 2011-11-22 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 26.07 | 130,330 |
| 2011-11-22 | Shak Steven (Chief Medical Officer) | Option Ex | 5,000 | 9.39 | 46,950 |
| 2011-11-22 | Baker Felix (Director) | Buy | 50,000 | 26.03 | 1,301,498 |
| 2011-11-21 | Baker Felix (Director) | Buy | 84,781 | 25.91 | 2,196,251 |
| 2011-11-16 | Baker Felix (Director) | Buy | 25,665 | 27.37 | 702,474 |
| 2011-11-15 | Baker Felix (Director) | Buy | 41,940 | 27.94 | 1,171,844 |
| 2011-11-14 | Baker Felix (Director) | Buy | 40,684 | 27.25 | 1,108,801 |
| 2011-11-11 | Scott Randal W (Executive Chairman) | Sale | 10,000 | 27.53 | 275,280 |
| 2011-11-11 | Baker Felix (Director) | Buy | 104,875 | 27.66 | 2,901,051 |
| 2011-11-10 | Scott Randal W (Executive Chairman) | Sale | 10,000 | 26.95 | 269,550 |
| 2011-11-10 | Baker Felix (Director) | Buy | 38,465 | 26.89 | 1,034,207 |
| 2011-11-09 | Baker Felix (Director) | Buy | 75,999 | 26.73 | 2,031,755 |
| 2011-11-08 | Cole G Bradley (COO) | Sale | 2,500 | 26.60 | 66,505 |
| 2011-11-08 | Cole G Bradley (COO) | Option Ex | 2,500 | 1.33 | 3,325 |
| 2011-11-07 | Baker Felix (Director) | Buy | 137,955 | 26.24 | 3,620,076 |
| 2011-11-04 | Baker Felix (Director) | Buy | 58,285 | 25.78 | 1,502,411 |
Insider trading activities including stock purchases, stock sales, and option exercises of GHDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.